VYogendrakumar Profile Banner
Vignan Yogendrakumar Profile
Vignan Yogendrakumar

@VYogendrakumar

Followers
213
Following
229
Media
11
Statuses
159

πŸ‡¨πŸ‡¦πŸ‡¦πŸ‡Ί Stroke Neurologist @OttawaHospital, PhD @UniMelbMDHS, MD @UBCMedicine, Interests in Stroke, ICH, & Clinical Trials

Melbourne, Victoria
Joined June 2019
Don't wanna be here? Send us removal request.
@VYogendrakumar
Vignan Yogendrakumar
8 months
Pleasure to be involved in this important project. Congrats @FaizanK91 !
@FaizanK91
Faizan Khan, PhD
8 months
πŸ“£πŸš¨I am incredibly happy and proud to share the Prognosis After Transient Ischemic Attack or Minor Stroke (PERSIST) study from my #BantingCanadaπŸ‡¨πŸ‡¦ postdoctoral fellowship published today in @JAMA_current! https://t.co/i0UTOe5J1a
0
0
3
@FishingNeurons
Urs Martin Fischer
8 months
Should we give IVT before EVR in stroke patients with tandem occlusion? Check our latest article in Lancet Neurology! @CheesemakerMD https://t.co/6k0HhcgBVm
0
14
36
@StrokeAHA_ASA
Stroke AHA/ASA
1 year
#STROKE This topical review by @VYogendrakumar et al. discusses the current state of emerging adjuvant treatments for acute ischemic stroke reperfusion.Β #AHAJournals @eva_mistry @mihill68 @RaulNogueiraMD @NguyenThanhMD @SCouttsMD https://t.co/6vf9v0Wm5Q
1
33
82
@NN_publishing
NeuroNews
1 year
.@VYogendrakumar delivers a @SELECT2Trial analysis revealing a link between substantial volumes of severe hypodensity and... - increased cerebral oedema - increased need for post-thrombectomy hemicraniectomy - no benefit of #Thrombectomy vs medical management #ESOC2024 @ESOstroke
0
13
30
@VYogendrakumar
Vignan Yogendrakumar
2 years
Thanks @StrokeAHA_ASA for setting up the concurrent publication! #WICH2023
@StrokeAHA_ASA
Stroke AHA/ASA
2 years
Exploring Hematoma Expansion Shift With Recombinant Factor VIIa: A Pooled Analysis of Four Randomized Controlled Trials #WICH2023 #stroke #AHAJournals @VYogendrakumar @stephanamayer https://t.co/V7dljGYD8W
1
2
16
@VYogendrakumar
Vignan Yogendrakumar
3 years
Latest results from the EXTEND-IA TNK Investigators. Had the pleasure of working with the team to look at tenecteplase performance in the context of LVOs with concurrent tandem lesions. @GeoffreyDonnan @MBCRMH
@GreenJournal
Neurology Journal
3 years
According to this study, #tenecteplase is associated with similar rates of intracranial reperfusion, functional outcome, mortality, and symptomatic intracranial hemorrhage compared with alteplase, in patients with acute #stroke due to tandem lesions. https://t.co/xDLrRqpN7c
0
0
7
@ANZSO_Stroke
Australian & New Zealand Stroke Organisation
3 years
#Stroke2023 Abstract submission deadline extended! Don't miss the opportunity to submit your abstract by 8 May, 2023.
0
5
7
@Vessel_Plus
Vessel Plus
3 years
#Stroke πŸ₯³Today's great review article! πŸ‘¨β€πŸ’Ό@AnnaBalabanski and Dr. Luke Burchill from @UniMelb research on a narrative review of stroke incidence, risk factors and #treatment in Indigenous Peoples of the world. 🌟Link: https://t.co/6nV3HiKBoM
0
2
6
@VYogendrakumar
Vignan Yogendrakumar
3 years
Thanks for the highlight @PoppeAY Latest work from the EXTEND-IA TNK Investigators. An exploratory analysis of TNK vs. tPA in Tandem Lesion strokes. No major safety concerns, but further work is required! @UniMelbMDHS @Teddyyhwu @GeoffreyDonnan @TimothyKleinig @ProfSteveDavis
@PoppeAY
Alexandre Poppe
3 years
Interesting (and reassuring) work from the EXTEND-TNK dataset suggesting that alteplase and tenecteplase are associated with similar outcomes in patients with tandem carotid lesions undergoing EVT. @VYogendrakumar
0
0
4
@VancouverStroke
Vancouver Stroke Program
3 years
Please join us tomorrow, Tuesday 28 Feb from 12-1 Vancouver time for our CVC rounds featuring Dr Vignan Yogendrakumar, who will be speaking to us from Melbourne about TNK in LVO stroke. Message us for the link!
1
2
11
@VYogendrakumar
Vignan Yogendrakumar
3 years
It was a pleasure to be one of the members of the @MBCRMH @UniMelbMDHS imaging analysis team for this study. Congrats @amrsarrajMD and @SELECT2Trial investigators!
@amrsarrajMD
Amrou Sarraj
3 years
Proud and honored to present @SELECT2Trial results at #ISC2023 EVT is safe and efficacious in large core! We’re a step closer to improving more patients lives.
1
0
4
@VYogendrakumar
Vignan Yogendrakumar
3 years
Happy to announce that a @MBCRMH imaging analysis of the EXTEND-IA TNK Trials has won the Paul Didley White Award during #ISC23 @TudorGJovin @AHAMeetings @AHAScience @ProfSteveDavis @Teddyyhwu @vthijs @GeoffreyDonnan Concurrent pub @StrokeAHA_ASA https://t.co/EvLscClpcQ
1
1
19
@VYogendrakumar
Vignan Yogendrakumar
3 years
Thanks @StrokeAHA_ASA for highlighting some of the latest work from the @MBCRMH Full presentation at #ISC23 on February 9th! Looking forward to seeing everyone there :)
@StrokeAHA_ASA
Stroke AHA/ASA
3 years
#ISC23 Tenecteplase Treatment and Thrombus Characteristics Associated With Early Reperfusion: An EXTEND-IA TNK Trials Analysis #stroke #AHAJournals https://t.co/VbWnlhuQ9S @VYogendrakumar @ProfSteveDavis @Teddyyhwu @vthijs @GeoffreyDonnan @DrBruceCampbell
0
2
7
@VYogendrakumar
Vignan Yogendrakumar
3 years
We show that across the time spectrum in LVO patients, TNK was superior to tPA in achieving lytic-induced reperfusion. Full details available in our #openaccess paper!
0
5
14
@VYogendrakumar
Vignan Yogendrakumar
3 years
Latest @ANA_journals publication from the @MBCRMH Stroke Team! In this latest analysis, we performed a comparative analysis of tPA and TNK induced reperfusion, accounting for the time from lytic to imaging assessment https://t.co/utMTjbWK5B
Tweet card summary image
onlinelibrary.wiley.com
Objective Tenecteplase improves reperfusion compared to alteplase in patients with large vessel occlusions. To determine whether this improvement varies across the spectrum of thrombolytic agent to...
1
8
20
@PoppeAY
Alexandre Poppe
3 years
Neurovascular fellowship positions for 2024 are available at CHUM! #CHUMStroke
4
28
63
@VYogendrakumar
Vignan Yogendrakumar
4 years
Congrats to the @MBCRMH research team on this achievement: the novel use of a mobile stroke unit to successfully conduct a clincial trial!
@TheLancetNeuro
The Lancet Neurology
4 years
NEW! Just published Online First, a phase 2 randomised trial of tenecteplase vs alteplase for early treatment of ischaemic stroke in the Melbourne Mobile Stroke Unit (TASTE-A) #ESOC2022
1
0
5
@VYogendrakumar
Vignan Yogendrakumar
4 years
Latest work from @MBCRMH: What is the effect of TXA on IVH growth? published in @ESOstroke journal. Early indications point to TXA being able to halt new IVH development. Future study in larger datasets will be required! Link below: https://t.co/PcNC9RTzo4
0
3
6
@VYogendrakumar
Vignan Yogendrakumar
4 years
Solid work by @san_murthy and co. providing further evidence of the impact of IVH expansion on outcome using CLEAR III data. Developing treatments that affect IVH growth, will be important in impacting clinical outcome
@san_murthy
Santosh Murthy
4 years
Our latest collaborative efforts to better understand IVH expansion led by @DRoh84 and thanks to @WendyZiai @jrmbernstein. @HopkinsNccu @WCMCNeurology @ColumbiaNCC @StrokeAHA_ASA
0
0
2
@ActRrct
AcT RRCT
4 years
Super excited to announce trial completion with a target of 1600😊 this would not have been possible without pan -Canadian team effort ! stay tuned for the results #tnkforstroke #givethejuice @DrRickSwartz @AlmekhlafiMa @mihill68 @nishita_singh3
3
13
67